Download PDF
Endoscopy 2003; 35(12): 1059-1068
DOI: 10.1055/s-2003-44604
Review
© Georg Thieme Verlag Stuttgart · New York

Photodynamic Therapy for Esophageal Diseases: A Clinical Update

R.  L.  Prosst1 , H.  C.  Wolfsen2 , J.  Gahlen1
  • 1 Department of Surgery, University Hospital Mannheim, Ruprecht-Karls-University, Heidelberg, Germany
  • 2 Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA
Further Information

Publication History

Submitted 26 June 2003

Accepted after Revision 9 July 2003

Publication Date:
27 November 2003 (online)

Also available at
    Permissions and Reprints

Photodynamic therapy (PDT) is a ”drug and device” therapy that combines the use of a photosensitizing agent and a photosensitizer (a drug that selectively accumulates and is preferentially retained in dysplastic or neoplastic cells). When activated by light of a specific wavelength in the presence of oxygen, the photoactive compound produces rapid cell death in the target tissue. While studied in nearly every area of medicine, PDT has been applied most extensively in the treatment of Barrett’s mucosa, dysplasia, and early and advanced cancer of the esophagus. This article represents an extensive survey of literature to review the experience gained with PDT and to assess its clinical value in the management of esophageal diseases.

References

  • 1 Oleinick N L, Evans H H. The photobiology of photodynamic therapy: cellular targets and mechanisms.  Radiat Res. 1998;  150 s146-s156
    PubMedGoogle Scholar
  • 2 Wang K K. Current status of photodynamic therapy of Barrett’s esophagus.  Gastrointest Endosc. 1999;  49 S20-S23
    PubMedGoogle Scholar
  • 3 Dougherty T J. An update on photodynamic therapy applications.  J Clin Laser Med Surg. 2002;  20 3-7
    CrossrefPubMedGoogle Scholar
  • 4 Conio M, Lapertosa G, Blanchi S. et al . Barrett’s esophagus: an update.  Crit Rev Oncol Hematol. 2003;  46 187-206
    PubMedGoogle Scholar
  • 5 Koop H. Gastroesophageal reflux disease and Barrett’s esophagus.  Endoscopy. 2002;  34 97-103
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Rosch T. Gastroesophageal reflux disease and Barrett’s esophagus.  Endoscopy. 2001;  33 909-916
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Birkmeyer J D, Siewers A E, Finlayson E V. et al . Hospital volume and surgical mortality in the United States.  N Engl J Med. 2002;  346 1128-1137
    CrossrefPubMedGoogle Scholar
  • 8 Ortner M A, Dorta G, Blum A L. et al . Endoscopic interventions for preneoplastic and neoplastic lesions: mucosectomy, argon plasma coagulation, and photodynamic therapy.  Dig Dis. 2002;  20 167-172
    CrossrefPubMedGoogle Scholar
  • 9 Leiper K, Morris A I. Treatment of oesophagogastric tumours.  Endoscopy. 2002;  34 139-145
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Kahaleh M, van Laethem J L, Nagy N. et al . Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression.  Endoscopy. 2002;  34 950-955
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 van Laethem J L, Jagodzinski R, Peny M O. et al . Argon plasma coagulation in the treatment of Barrett’s high-grade dysplasia and in situ adenocarcinoma.  Endoscopy. 2001;  33 257-261
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Enns R A. Prospective randomized trial of argon plasma coagulation versus multipolar electrocoagulation in the ablation of Barrett’s esophagus without dysplasia: preliminary results.  Gastroenterology. 2002;  122 A685
    PubMedGoogle Scholar
  • 13 Wolfsen H C. Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett’s esophagus.  Dig Dis. 2002;  20 5-17
    CrossrefPubMedGoogle Scholar
  • 14 Marcon N E. Photodynamic therapy and cancer of the esophagus.  Semin Oncol. 1994;  21 20-23
    PubMedGoogle Scholar
  • 15 Bown S G, Rogowska A Z. New photosensitizers for photodynamic therapy in gastroenterology.  Can J Gastroenterol. 1999;  13 389-392
    PubMedGoogle Scholar
  • 16 Overholt B F, Panjehpour M, Haydek J M. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients.  Gastrointest Endosc. 1999;  49 1-7
    CrossrefPubMedGoogle Scholar
  • 17 Wolfsen H C, Woodward T A, Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma.  Mayo Clin Proc. 2002;  77 1176-1181
    PubMedGoogle Scholar
  • 18 Panjehpour M, Overholt B F, Haydek J M. et al . Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s esophagus and effect of oral steroids on stricture formation.  Am J Gastroenterol. 2000;  95 2177-2184
    CrossrefPubMedGoogle Scholar
  • 19 Gossner L, Stolte M, Sroka R. et al . Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid.  Gastroenterology. 1998;  114 448-455
    PubMedGoogle Scholar
  • 20 Gossner L, May A, Sroka R. et al . Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after the oral administration of 5-aminolevulinic acid.  Cancer. 1999;  86 1921-1928
    CrossrefPubMedGoogle Scholar
  • 21 Gossner L, May A, Sroka R. et al . A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.  Endoscopy. 1999;  31 370-376
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Javaid B, Watt P, Krasner N. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study.  Lasers Med Sci. 2002;  17 51-56
    CrossrefPubMedGoogle Scholar
  • 23 Ackroyd R, Brown N J, Davis M F. et al . Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial.  Gut. 2000;  47 612-617
    CrossrefPubMedGoogle Scholar
  • 24 Ackroyd R, Brown N J, Davis M F. et al . Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett’s esophagus.  Dis Esoph. 2000;  13 18-22
    PubMedGoogle Scholar
  • 25 Barr H, Shepherd N A, Dix A. et al . Eradication of high-grade dysplasia in columnar-lined (Barrett’s) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.  Lancet. 1996;  348 584-585
    CrossrefPubMedGoogle Scholar
  • 26 Orth K, Stanescu A, Ruck A. et al . [Photodynamic ablation and argon-plasma coagulation of premalignant and early-stage malignant lesions of the oesophagus - an alternative to surgery?].  Chirurg. 1999;  70 431-438
    CrossrefPubMedGoogle Scholar
  • 27 Ortner M A, Zumbusch K, Liebetruth J. et al . Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett’s esophagus? A pilot study.  Endoscopy. 2002;  34 611-616
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 McCaughan J S, Jr., Ellison E C, Guy J T. et al . Photodynamic therapy for esophageal malignancy: a prospective twelve-year study.  Ann Thorac Surg. 1996;  62 1005-1009
    PubMedGoogle Scholar
  • 29 Corti L, Skarlatos J, Boso C. et al . Outcome of patients receiving photodynamic therapy for early esophageal cancer.  Int J Radiat Oncol Biol Phys. 2000;  47 419-424
    CrossrefPubMedGoogle Scholar
  • 30 Gossner L, May A, Pech O. et al . Photodynamic therapy of Barrett’s esophagus with dysplasia or early cancer [abstract].  Gastroenterology. 1999;  116 A413
    PubMedGoogle Scholar
  • 31 Tan W C, Fulljames C, Stone N. et al . Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett’s metaplasia.  J Photochem Photobiol B. 1999;  53 75-80
    CrossrefPubMedGoogle Scholar
  • 32 Maier A, Anegg U, Fell B. et al . Hyperbaric oxygen and photodynamic therapy in the treatment of advanced carcinoma of the cardia and the esophagus.  Lasers Surg Med. 2000;  26 308-315
    CrossrefPubMedGoogle Scholar
  • 33 Regula J, MacRobert A J, Gorchein A. et al . Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX - a pilot study.  Gut. 1995;  36 67-75
    PubMedGoogle Scholar
  • 34 Tian M E, Qui S L, Ji Q. Preliminary results of hematoporphyrin derivative-laser treatment for 13 cases of early esophageal carcinoma.  Adv Exp Med Biol. 1985;  193 21-25
    PubMedGoogle Scholar
  • 35 Fujimaki M, Nakayama K. Endoscopic laser treatment of superficial esophageal cancer.  Semin Surg Oncol. 1986;  2 248-256
    PubMedGoogle Scholar
  • 36 Tajiri H, Daikuzono N, Joffe S N. et al . Photoradiation therapy in early gastrointestinal cancer.  Gastrointest Endosc. 1987;  33 88-90
    PubMedGoogle Scholar
  • 37 Hayata Y, Kato H, Konaka C. et al . [Laser endoscopy in photodynamic therapy].  Chirurg. 1988;  59 81-89
    PubMedGoogle Scholar
  • 38 Okunaka T, Kato H, Conaka C. et al . Photodynamic therapy of esophageal carcinoma.  Surg Endosc. 1990;  4 150-153
    PubMedGoogle Scholar
  • 39 Grosjean P, Wagnieres G, Fontolliet C. et al . Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II.  Br J Cancer. 1998;  77 1989-1995
    PubMedGoogle Scholar
  • 40 Sibille A, Lambert R, Souquet J C. et al . Long-term survival after photodynamic therapy for esophageal cancer.  Gastroenterology. 1995;  108 337-344
    PubMedGoogle Scholar
  • 41 Lightdale C J, Heier S K, Marcon N E. et al . Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial.  Gastrointest Endosc. 1995;  42 507-512
    CrossrefPubMedGoogle Scholar
  • 42 Heier S K, Rothman K A, Heier L M. et al . Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy.  Gastroenterology. 1995;  109 63-72
    PubMedGoogle Scholar
  • 43 Jin M, Yang B, Zhang W. et al . Photodynamic therapy for upper gastrointestinal tumours over the past 10 years.  Semin Surg Oncol. 1994;  10 111-113
    PubMedGoogle Scholar
  • 44 Luketich J D, Christie N A, Buenaventura P O. et al . Endoscopic photodynamic therapy for obstructing esophageal cancer: 77 cases over a 2-year period.  Surg Endosc. 2000;  14 653-657
    CrossrefPubMedGoogle Scholar
  • 45 Scheider D M, Siemens M, Cirocco M. et al . Photodynamic therapy for the treatment of tumor ingrowth in expandable esophageal stents.  Endoscopy. 1997;  29 271-274
    PubMedGoogle Scholar
  • 46 Savary J F, Grosjean P, Monnier P. et al . Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases.  Endoscopy. 1998;  30 258-265
    Article in Thieme ConnectPubMedGoogle Scholar
  • 47 Savary J F, Monnier P, Fontolliet C. et al . Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.  Arch Otolaryngol Head Neck Surg. 1997;  123 162-168
    PubMedGoogle Scholar
  • 48 Grosjean P, Savary J-F, Wagnieres G. et al . Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers.  Lasers Med Sci. 1996;  11 227-235
    PubMedGoogle Scholar
  • 49 Mlkvy P, Messmann H, Regula J. et al . Photodynamic therapy for gastrointestinal tumors using three photosensitizers - ALA induced PPIX, Photofrin and MTHPC. A pilot study.  Neoplasma. 1998;  45 157-161
    PubMedGoogle Scholar
  • 50 Maier A, Tomaselli F, Matzi V. et al . Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma.  Ann Thorac Surg. 2001;  72 1136-1140
    CrossrefPubMedGoogle Scholar
  • 51 Maier A, Tomaselli F, Matzi V. et al . Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma?.  Lasers Med Sci. 2001;  29 323-327
    PubMedGoogle Scholar
  • 52 van den Bergh H. On the evolution of some endoscopic light delivery systems for photodynamic therapy.  Endoscopy. 1998;  30 392-407
    PubMedGoogle Scholar
  • 53 Panjehpour M, Overholt B F, Haydek J M. Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract.  Gastrointest Endosc Clin N Am. 2000;  10 513-532
    PubMedGoogle Scholar
  • 54 Overholt B F, Panjehpour M, DeNovo R C. et al . Balloon photodynamic therapy of esophageal cancer: effect of increasing balloon size.  Lasers Surg Med. 1996;  18 248-252
    CrossrefPubMedGoogle Scholar
  • 55 Stepinac T, Grosjean P, Woodtli A. et al . Optimization of the diameter of a radial irradiation device for photodynamic therapy in the esophagus.  Endoscopy. 2002;  34 411-415
    Article in Thieme ConnectPubMedGoogle Scholar
  • 56 Braichotte D R, Savary J F, Monnier P. et al . Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy.  Lasers Surg Med. 1996;  19 340-346
    CrossrefPubMedGoogle Scholar
  • 57 Zellweger M, Grosjean P, Monnier P. et al . Stability of the fluorescence measurement of Foscan in the normal human oral cavity as an indicator of its content in early cancers of the esophagus and the bronchi.  Photochem Photobiol. 1999;  69 605-610
    CrossrefPubMedGoogle Scholar
  • 58 Radu A, Conde R, Fontolliet C. et al . Mucosal ablation with photodynamic therapy in the esophagus: optimization of light dosimetry in the sheep model.  Gastrointest Endosc. 2003;  57 897-905
    PubMedGoogle Scholar
  • 59 Cheung R, Solonenko M, Busch T M. et al . Correlation of in vivo photosensitizer fluorescence and photodynamic therapy-induced depth of necrosis in a murine tumor model.  J Biomed Opt. 2003;  8 248-252
    CrossrefPubMedGoogle Scholar
  • 60 Overholt B F, Panjehpour M. Photodynamic therapy for Barrett’s esophagus.  Gastrointest Endosc Clin N Am. 1997;  7 207-220
    PubMedGoogle Scholar
  • 61 Wolfsen H C, Ng C S. Cutaneous consequences of photodynamic therapy.  Cutis. 2002;  69 140-142
    PubMedGoogle Scholar
  • 62 Dolmans D E, Fukumura D, Jain R K. Photodynamic therapy for cancer.  Nat Rev Cancer. 2003;  3 380-387
    CrossrefPubMedGoogle Scholar
  • 63 Inoue H, Tani M, Nagai K. et al . Treatment of esophageal and gastric tumors.  Endoscopy. 1999;  31 47-55
    Article in Thieme ConnectPubMedGoogle Scholar
  • 64 Shim C S. Role of endoscopic ultrasonography for gastric lesions.  Endoscopy. 1998;  30 (Suppl 1) A55-A59
    PubMedGoogle Scholar
  • 65 Soetikno R M, Gotoda T, Nakanishi Y. et al . Endoscopic mucosal resection.  Gastrointest Endosc. 2003;  57 567-579
    CrossrefPubMedGoogle Scholar
  • 66 Moreto M. Diagnosis of esophagogastric tumors.  Endoscopy. 2003;  35 36-42
    Article in Thieme ConnectPubMedGoogle Scholar
  • 67 Shim C S. Endoscopic mucosal resection: an overview of the value of different techniques.  Endoscopy. 2001;  33 271-275
    Article in Thieme ConnectPubMedGoogle Scholar
  • 68 Rembacken B J, Gotoda T, Fujii T. et al . Endoscopic mucosal resection.  Endoscopy. 2001;  33 709-718
    Article in Thieme ConnectPubMedGoogle Scholar
  • 69 Nijhawan P K, Wang K K. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagus.  Gastrointest Endosc. 2000;  52 328-332
    CrossrefPubMedGoogle Scholar
  • 70 Ell C, May A, Gossner L. et al . Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus.  Gastroenterology. 2000;  118 670-677
    CrossrefPubMedGoogle Scholar
  • 71 May A, Gossner L, Pech O. et al . Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett’s esophagus (SSBE): curative treatment using local endoscopic treatment techniques.  Endoscopy. 2002;  34 604-610
    Article in Thieme ConnectPubMedGoogle Scholar
  • 72 Al-Kasspooles M F, Hill H C, Nava H R. et al . High-grade dysplasia within Barrett’s esophagus: controversies regarding clinical opinions and approaches.  Ann Surg Oncol. 2002;  9 222-227
    CrossrefPubMedGoogle Scholar
  • 73 Buttar N S, Wang K K, Lutzke L S. et al . Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus.  Gastrointest Endosc. 2001;  54 682-688
    PubMedGoogle Scholar
  • 74 Montgomery E, Bronner M P, Goldblum J R. et al . Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.  Hum Pathol. 2001;  32 368-378
    CrossrefPubMedGoogle Scholar
  • 75 Edwards M J, Gable D R, Lentsch A B. et al . The rationale for esophagectomy as the optimal therapy for Barrett’s esophagus with high-grade dysplasia.  Ann Surg. 1996;  223 585-589; discussion 9 - 91
    CrossrefPubMedGoogle Scholar
  • 76 Ferguson M K, Naunheim K S. Resection for Barrett’s mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy.  J Thorac Cardiovasc Surg. 1997;  114 824-829
    PubMedGoogle Scholar
  • 77 Krishnadath K K, Wang K K, Taniguchi K. et al . Persistent genetic abnormalities in Barrett’s esophagus after photodynamic therapy.  Gastroenterology. 2000;  119 624-630
    CrossrefPubMedGoogle Scholar
  • 78 Bourre L, Thibaut S, Briffaud A. et al . Potential efficacy of a delta 5-aminolevulinic acid thermosetting gel formulation for use in photodynamic therapy of lesions of the gastrointestinal tract.  Pharmacol Res. 2002;  45 159-165
    CrossrefPubMedGoogle Scholar
  • 79 Zopf T, Rosenbaum A, Apel D. et al . [Photodynamic therapy of dysplasias and early carcinomas in Barrett esophagus with a diode laser system - a pilot study].  Med Klin. 2001;  96 212-216
    PubMedGoogle Scholar
  • 80 Brand R E. Going all the way?.  Am J Gastroenterol. 2000;  95 3032-3033
    PubMedGoogle Scholar
  • 81 Bourg-Heckly G, Blais J, Padilla J J. et al . Endoscopic ultraviolet-induced autofluorescence spectroscopy of the esophagus: tissue characterization and potential for early cancer diagnosis.  Endoscopy. 2000;  32 756-765
    Article in Thieme ConnectPubMedGoogle Scholar
  • 82 Li X D, Boppart S A, Van Dam J. et al . Optical coherence tomography: advanced technology for the endoscopic imaging of Barrett’s esophagus.  Endoscopy. 2000;  32 921-930
    Article in Thieme ConnectPubMedGoogle Scholar
  • 83 Canto M I, Yoshida T, Gossner L. Chromoscopy of intestinal metaplasia in Barrett’s esophagus.  Endoscopy. 2002;  34 330-336
    Article in Thieme ConnectPubMedGoogle Scholar
  • 84 Lambert R. Diagnosis of esophagogastric tumors.  Endoscopy. 2002;  34 129-138
    Article in Thieme ConnectPubMedGoogle Scholar
  • 85 Shim C S. Staining in gastrointestinal endoscopy: clinical applications and limitations.  Endoscopy. 1999;  31 487-496
    Article in Thieme ConnectPubMedGoogle Scholar

R. L. Prosst,M. D. 

Chirurgische Universitätsklinik Mannheim

Theodor-Kutzer-Ufer 1 - 3 · 68167 Mannheim · Germany

Fax: +49-621-383-2109

Email: ruediger@prosst.de